August 2008 - Volume 48 - Issue 2 : Hepatology

Secondary Logo

Journal Logo

August 2008 - Volume 48 - Issue 2
pp: 353-695

R1626 plus peginterferon Alfa‐2a provides potent suppression of hepatitis C virus RNA and significant antiviral synergy in combination with ribavirin†

Pockros, Paul J.; Nelson, David; Godofsky, Eliot; More

Hepatology. 48(2):385-397, August 2008.

Albinterferon alfa‐2b dosed every two or four weeks in interferon‐naïve patients with genotype 1 chronic hepatitis C†‡

Zeuzem, Stefan; Yoshida, Eric M.; Benhamou, Yves; More

Hepatology. 48(2):407-417, August 2008.

PDF Only


Retracted: Outcome and immune reconstitution of HBV‐specific immunity in patients with reactivation of occult HBV infection after alemtuzumab‐containing chemotherapy regimen†

Hui, Chee‐Kin; Cheung, Winnie W.; Leung, Kar‐Wai; More

Hepatology. 48(2):, August 2008.




Hepatic AdipoR2 signaling plays a protective role against progression of nonalcoholic steatohepatitis in mice†

Tomita, Kengo; Oike, Yuichi; Teratani, Toshiaki; More

Hepatology. 48(2):458-473, August 2008.

Dietary cholesterol, rather than liver steatosis, leads to hepatic inflammation in hyperlipidemic mouse models of nonalcoholic steatohepatitis†

Wouters, Kristiaan; van Gorp, Patrick J.; Bieghs, Veerle; More

Hepatology. 48(2):474-486, August 2008.


Identification of novel immunohistochemical tumor markers for primary hepatocellular carcinoma; clathrin heavy chain and formiminotransferase cyclodeaminase†

Seimiya, Masanori; Tomonaga, Takeshi; Matsushita, Kazuyuki; More

Hepatology. 48(2):519-530, August 2008.


Loss of tolerance in C57BL/6 mice to the autoantigen E2 subunit of pyruvate dehydrogenase by a xenobiotic with ensuing biliary ductular disease†

Wakabayashi, Kanji; Lian, Zhe‐Xiong; Leung, Patrick S.C.; More

Hepatology. 48(2):531-540, August 2008.

Show:
  NODES
Association 1
Note 1